Biomarkers for Risk Assessment and Prevention of Breast Cancer
Journal:
Current Cancer Drug Targets
Volume:
9
Page:
482-499
Author(s):
Massimiliano Cazzaniga, Andrea Decensi, Bernardo Bonanni, Alberto Luini and Oreste Gentilini
Potential Uses of MicroRNA in Lung Cancer Diagnosis, Prognosis, and Therapy
Journal:
Current Cancer Drug Targets
Volume:
9
Page:
572-594
Author(s):
Qi Zhao Wang, William Xu, Nagy Habib and Ruian Xu
Novel Tyrosine Kinase Inhibitors in the Treatment of Cancer
Journal:
Current Drug Targets
Volume:
10
Page:
575-576
Author(s):
Alberto Ocana, Rosario Serrano, Raul Calero and Atanasio Pandiella
Role of Lipoxins and Resolvins as Anti-Inflammatory and Proresolving Mediators in Colon Cancer
Journal:
Current Molecular Medicine
Volume:
9
Page:
565-579
Author(s):
Naveena B. Janakiram and Chinthalapally V. Rao
Gene Therapy Targeting Nuclear Factor-κB: Towards Clinical Application in Inflammatory Diseases and Cancer
Journal:
Current Gene Therapy
Volume:
9
Page:
160-170
Author(s):
Sander W. Tas, Margriet J.B.M. Vervoordeldonk and Paul P. Tak
The CLCA Gene Family: Putative Therapeutic Target for Respiratory Diseases
Journal:
Inflammation & Allergy - Drug Targets (Discontinued)
Volume:
8
Page:
146-160
Author(s):
John P. Winpenny, Laura L. Marsey and Darren W. Sexton
Retinoids as Critical Modulators of Immune Functions: New Therapeutic Perspectives for Old Compounds
Journal:
Endocrine, Metabolic & Immune Disorders - Drug Targets
Volume:
9
Page:
113-131
Author(s):
Michele Montrone, Debora Martorelli, Antonio Rosato and Riccardo Dolcetti
Targeting Indoleamine 2,3-dioxygenase (IDO) to Counteract Tumour- Induced ImmuneDysfunction: From Biochemistry to Clinical Development
Journal:
Endocrine, Metabolic & Immune Disorders - Drug Targets
Volume:
9
Page:
151-177
Author(s):
S. Rutella, G. Bonanno and R. De Cristofaro
Yeast-Derived β-Glucan in Combination with Anti-Tumor Monoclonal Antibody Therapy in Cancer
Journal:
Recent Patents on Anti-Cancer Drug Discovery
Volume:
4
Page:
101-109
Author(s):
Jingjing Liu, Lacey Gunn, Richard Hansen and Jun Yan
Targeting RhoA/Rho Kinase and p21-Activated Kinase Signaling to Prevent Cancer Development and Progression
Journal:
Recent Patents on Anti-Cancer Drug Discovery
Volume:
4
Page:
110-124
Author(s):
Yu-Wen E. Chang, Ronald R. Bean and Rolf Jakobi